Enzyme discovery offers new direction in diabetes
A team of Australian scientists has found an enzyme in diabetics that prevents them from producing insulin. The researchers say that they intend to start working with drug developers to block PKCepsilon, raising the possibility of a simple, effective method for treating diabetes. Observers also noted that the advancement could create a therapy that would protect people at high risk from ever developing Type 2 diabetes. In an animal study, the team developed genetically modified mice without the enzyme, and found that they didn't develop diabetes even after gaining a significant amount of weight on a high-fat diet.
- see the release on the discovery
- read the the report from ABC
Related Articles:
New way to creating enzymes. Report
Diabetes epidemic triggers soaring drug market. Report
Diabetes therapies move into the research spotlight. Report
Be the first to comment Rate it:
Comments
Post new comment
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight